Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125261391 | 12526139 | 1 | I | 20160630 | 0 | 20160701 | 20160701 | DIR | 39.00 | YR | F | N | 125.00000 | LBS | 20160630 | N | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125261391 | 12526139 | 1 | PS | SUBOXONE | BUPRENORPHINE HYDROCHLORIDENALOXONE HYDROCHLORIDE | 1 | Sublingual | Y | D | A16GW108 | 20170630 | 0 | 60 | DF | BID | ||||
| 125261391 | 12526139 | 2 | C | CELEXA | CITALOPRAM HYDROBROMIDE | 1 | 0 | ||||||||||||
| 125261391 | 12526139 | 3 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | 0 | ||||||||||||
| 125261391 | 12526139 | 4 | C | NIFEDIPINE. | NIFEDIPINE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125261391 | 12526139 | 1 | Drug dependence |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125261391 | 12526139 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125261391 | 12526139 | Blood pressure increased | |
| 125261391 | 12526139 | Impaired work ability | |
| 125261391 | 12526139 | Peripheral swelling | |
| 125261391 | 12526139 | Raynaud's phenomenon | |
| 125261391 | 12526139 | Skin discolouration | |
| 125261391 | 12526139 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125261391 | 12526139 | 1 | 20160301 | 20160620 | 0 |